Teva plans NBA-themed campaign for re-branded ProAir.
Teva Specialty Pharmaceuticals--which has been breathing easy since FDA mandated the use of more environmentally friendly asthma inhalers--is hoping for a slam dunk with a new disease-awareness campaign featuring NBA players. The company, which makes the ProAir (albuterol) and Qvar (beclomethasone) inhaler brands, is teaming up with the basketball association as well as the Asthma and Allergy Foundation of America to educate fans about how to prevent and manage the disease.
The campaign--dubbed "Are You Ready to Go Pro?"--plays on ProAir's brand name, which was changed last July with the tagline "Our name has gone pro." Teva is one of four firms that reformulated their inhalers with hydrofluoroalkane (HFA) rather than chlorofluorocarbons (CFC) in their propulsion systems. Since CFC inhalers must be phased out of circulation by the end of 2008, a market that was once squarely in the hands of generics makers is now up for grabs.
With limited competition, Teva, it seems, is off and running. The latest figures from IMS Health show that the company has captured 66 percent of the HFA market, and Citibank is predicting 390 percent growth this year for ProAir--for a total of $270 million in sales.
Teva--which is largely known as a generics makers but acquired branded products as part of its merger with Ivax--is also running separate branded campaigns for the two products. During last year's third-quarter earnings call, George Barrett, president and CEO of Teva North America, spoke about the complexities of switching patients from its generic CFC drugs to the branded HFA products.
"We built a small sales force, but this is going to be a unique situation, which in a way involves the physician but also in a way involves the pay orders and the resell chains," he said. "And we are going to work with all of our tools across both our branded and our generics enterprise to supply to that market."
The NBA campaign centers on a sweepstakes in which fans can win a free trip to the 2007 draft by writing an essay entitled "How I (or My Family) Stay(s) Active With Asthma." Several current and former players are asthma sufferers. Facts about the medical condition will also be posted on the Web site www.readytogopro.com, and displayed at NBA events like the All-Star Jam Session and the Summer Tour.
Young & Partners Pharmaceutical Executive Summit 2024: Brave New World – Where Are We Heading?
October 23rd 2024Peter Marks, director, Center for Biologics Evaluation and Research, FDA, presented the keynote presentation on the future of gene therapy as part of the 20th Annual Young & Partners Pharmaceutical Executive Summit held at the Yale Club of New York.
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
Unlocking value and cost savings in patient services with technology and talent
October 2nd 2024Traci Miller, Director, Sonexus™ Access and Patient Support, Cardinal Health, discusses the current digital trends in the patient services industry and how the optimal balance of technology and talent can transform manufacturer-sponsored patient support programs. Hear how Cardinal Health combines best-in-class program and pharmacy operations with smart digital tools to ensure product and patient success and reduce operational costs.